SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-038644
Filing Date
2020-08-10
Accepted
2020-08-10 08:23:39
Documents
61
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q ovid-10q_20200630.htm 10-Q 2296948
2 EX-31.1 ovid-ex311_6.htm EX-31.1 21245
3 EX-31.2 ovid-ex312_8.htm EX-31.2 21509
4 EX-32.1 ovid-ex321_7.htm EX-32.1 8089
5 GRAPHIC gmsuly2uvlwl000001.jpg GRAPHIC 34718
  Complete submission text file 0001564590-20-038644.txt   6512906

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT ovid-20200630.xml EX-101.INS 1155850
7 XBRL TAXONOMY EXTENSION SCHEMA ovid-20200630.xsd EX-101.SCH 43790
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ovid-20200630_cal.xml EX-101.CAL 33844
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ovid-20200630_def.xml EX-101.DEF 178329
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE ovid-20200630_lab.xml EX-101.LAB 355909
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ovid-20200630_pre.xml EX-101.PRE 282441
Mailing Address 1460 BROADWAY SUITE 15044 NEW YORK NY 10036
Business Address 1460 BROADWAY SUITE 15044 NEW YORK NY 10036 212-776-4381
Ovid Therapeutics Inc. (Filer) CIK: 0001636651 (see all company filings)

IRS No.: 465270895 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38085 | Film No.: 201087226
SIC: 2834 Pharmaceutical Preparations